
Michael J. Sheppeard
Partner
212-784-6939 msheppeard@sh-law.comFirm Insights
Author: Michael J. Sheppeard
Date: September 29, 2020

Partner
212-784-6939 msheppeard@sh-law.comAlthough COVID-19 remains a top compliance concern for New York and New Jersey employers, it’s important to remember that regulators continue to address a wide range of other issues. On August 5, 2020, the Equal Employment Opportunity Commission (EEOC) released new guidance regarding opioid addiction and employment.

Opioid misuse and associated overdoses have become a public health crisis over the past several years. By definition, “opioids” include prescription drugs such as codeine, morphine, oxycodone, hydrocodone, and meperidine, as well as illegal drugs like heroin.
In 2016, opioid overdoses accounted for more than 42,000 deaths, more than any previous year on record. Of the overdose deaths, approximately 40% involved a prescription opioid. Data collected in 2018 data shows that 128 people in the United States die after overdosing on opioids every day.
The opioid crisis does not just impact drug users and their families. According to the Centers for Disease Control and Prevention estimates that the total “economic burden” of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.
Opioids are also a concern for employers. Substance use disorder impacts workplace safety, health care costs, productivity, absenteeism, and job performance.
The EEOC’s recent guidance, Use of Codeine, Oxycodone, and Other Opioids: Information for Employees, addresses how employers must address opioid use by employees under the ADA. It makes clear that current illegal drug use is not a covered disability. Accordingly, if a worker is using heroin or opioid medication without a valid prescription, the ADA does not prohibit employers from firing employees, denying employment to job applicants, or taking other negative employment actions based on the current illegal use of drugs.
Conversely, workers who are lawfully using opioid medication, are in treatment for opioid addiction and are receiving Medication-Assisted Treatment (MAT), or have been in recovery for their addiction, are protected from discrimination under the ADA. Accordingly, if an employee’s opioid use is legal, employers can’t automatically disqualify the employee because of opioid use without considering if there is a way for the employee to perform the job safely and effectively. In such cases, employers may be required to provide a reasonable accommodation.
Below are several other key takeaways from the EEOC guidance:
The EEOC also published additional guidance aimed at health professionals. The document, entitled “How Health Care Providers Can Help Current and Former Patients Who Have Used Opioids Stay Employed,” addresses patients’ legal rights in the workplace. As the EEOC notes, medical providers are often key participants in the interactive process between employers and workers as employers seek to understand the employee’s condition and potential need for reasonable accommodation. The fact sheet provides an overview of ADA coverage and offers guidance to health care workers seeking to provide documentation of covered disabilities on behalf of their patients.
While opioid-related deaths declined in 2019, health experts expect that the ongoing COVID-19 pandemic will fuel the crisis. To maintain a healthy workplace, employers should encourage workers to use their health insurance as well as any available Employee Assistance Program (EAP) to address their mental or chemical health needs. Employers may also want to consider policies and procedures that promote overall wellness and self-care, support long-term recovery, and seek to reduce stigma surrounding drug use for those seeking assistance. With regard to regulatory compliance, it is important that employers understand their obligations under laws like ADA. As the EEOC guidance highlights, employers have certain obligations to accommodate an employee’s opioid use and treatment for opioid addiction under the law.
If you have any questions or if you would like to discuss the matter further, please contact me, Michael Sheppeard, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

Small businesses considering buying commercial property in New Jersey must evaluate a range of legal, financial, and operational factors. While ownership can offer long-term value and control, it also introduces significant risks if not properly structured. This guide outlines key considerations to help New Jersey business owners make informed decisions, minimize legal exposure, and successfully […]
Author: Robert L. Baker, Jr.

On January 28, 2026, staff of the U.S. Securities and Exchange Commission’s Divisions of Corporation Finance, Investment Management, and Trading and Markets issued a joint statement clarifying how existing federal securities laws apply to tokenized securities. The SEC’s “Statement on Tokenized Securities” does not establish new law, but it does provide greater clarity on the […]
Author: Dan Brecher

Operating a business in the New Jersey and New York City metropolitan region offers incredible opportunities, but it also requires navigating a dense and highly regulated legal environment. From entity formation to regulatory compliance, seemingly minor legal oversights can expose business owners to significant risk. In our work with businesses throughout the region, our attorneys […]
Author: Dan Brecher

High-profile founder litigation is more than just a media spectacle. For startup founders, these cases underscore the legal and structural risks that can arise when rapid growth outpaces formal oversight. While launching a new company can be both an exciting and deeply rewarding endeavor, founders must be mindful that it also comes with significant risks. […]
Author: Dan Brecher

Every New Jersey company should periodically evaluate its governance framework. Strong corporate governance protects directors and officers, builds investor confidence, reduces litigation exposure, and positions a company for sustainable growth. The first quarter of the year is a great time to evaluate your corporate governance practices and perform any routine maintenance needed to keep that […]
Author: Ken Hollenbeck

Being served with a lawsuit is one of the most stressful legal events a business or individual can face. Whether the claim involves a contract dispute, an employment matter, an intellectual property issue, or another legal challenge, the actions you take in the first few days can significantly shape the outcome of your case. Acting […]
Author: Robert E. Levy
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!